Affimed Announces Milestone Payment from Genentech and ROCK® Platform Presentation at Innate Killer Summit 2019, Further Highlighting Leadership in Innate Immunity

by NASDAQ Market News March 19, 2019

NASDAQ Market News
Click here to email author

Global Hepatitis Partnering Analysis 2019: Deals and Agreement by the World’s Leading healthcare Companies Since 2014

FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer

Ads